Editorial
Emphasizing the timing and procedure selection for vitrectomy in pathological myopic traction maculopathy
Wei Wenbin, Shao Lei, Zhou Wenda
Published 2024-03-11
Cite as Chin J Ophthalmol, 2024, 60(3): 211-214. DOI: 10.3760/cma.j.cn112142-20231221-00299
Abstract
Myopic maculopathy is the primary cause of irreversible visual impairment in patients with pathologic myopia, and myopic traction maculopathy often requires vitrectomy for treatment. Myopic traction maculopathy encompasses epiretinal membrane, foveoschisis, macular hole, and macular hole-related retinal detachment. It is recommended to perform vitrectomy combined with inner limiting membrane peeling for Type II epiretinal membrane, foveal-sparing inner limiting membrane peeling for foveoschisis, inverted inner limiting membrane flap technique for macular hole, and vitrectomy combined with macular buckle for refractory macular hole-related retinal detachment. Myopic traction maculopathy is a chronically progressive condition, and surgeons need to accurately determine the timing of surgery and choose appropriate procedures to maximize the benefits for patients.
Key words:
Myopia, degenerative; Macular degeneration; Vitrectomy; Internal limiting membrane peeling; Operative time
Contributor Information
Wei Wenbin
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology &
Visual Sciences, Beijing 100730, China
Shao Lei
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology &
Visual Sciences, Beijing 100730, China
Zhou Wenda
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology &
Visual Sciences, Beijing 100730, China